Systemic Inflammatory Response Syndrome Criteria in Defining Severe Sepsis

被引:811
作者
Kaukonen, Kirsi-Maija [1 ,5 ]
Bailey, Michael [1 ]
Pilcher, David [1 ,2 ,3 ]
Cooper, D. Jamie [1 ]
Bellomo, Rinaldo [1 ,4 ]
机构
[1] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia
[2] Australian & New Zealand Intens Care Soc, Ctr Outcome & Resource Evaluat, Melbourne, Vic, Australia
[3] Alfred Hosp, Dept Intens Care, Melbourne, Vic, Australia
[4] Austin Hlth, Intens Care Unit, Heidelberg, Vic, Australia
[5] Univ Helsinki, Cent Hosp, Dept Anesthesiol Intens Care & Pain Med, Neurosurg Unit, Helsinki, Finland
关键词
GOAL-DIRECTED RESUSCITATION; NEW-ZEALAND RISK; MORTALITY; ADULTS; PREDICTION; THERAPY; TIME; SIRS;
D O I
10.1056/NEJMoa1415236
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The consensus definition of severe sepsis requires suspected or proven infection, organ failure, and signs that meet two or more criteria for the systemic inflammatory response syndrome (SIRS). We aimed to test the sensitivity, face validity, and construct validity of this approach. METHODS We studied data from patients from 172 intensive care units in Australia and New Zealand from 2000 through 2013. We identified patients with infection and organ failure and categorized them according to whether they had signs meeting two or more SIRS criteria (SIRS-positive severe sepsis) or less than two SIRS criteria (SIRS-negative severe sepsis). We compared their characteristics and outcomes and assessed them for the presence of a step increase in the risk of death at a threshold of two SIRS criteria. RESULTS Of 1,171,797 patients, a total of 109,663 had infection and organ failure. Among these, 96,385 patients (87.9%) had SIRS-positive severe sepsis and 13,278 (12.1%) had SIRS-negative severe sepsis. Over a period of 14 years, these groups had similar characteristics and changes in mortality (SIRS-positive group: from 36.1% [829 of 2296 patients] to 18.3% [2037 of 11,119], P<0.001; SIRS-negative group: from 27.7% [100 of 361] to 9.3% [122 of 1315], P<0.001). Moreover, this pattern remained similar after adjustment for baseline characteristics (odds ratio in the SIRS-positive group, 0.96; 95% confidence interval [CI], 0.96 to 0.97; odds ratio in the SIRS-negative group, 0.96; 95% CI, 0.94 to 0.98; P = 0.12 for between-group difference). In the adjusted analysis, mortality increased linearly with each additional SIRS criterion (odds ratio for each additional criterion, 1.13; 95% CI, 1.11 to 1.15; P<0.001) without any transitional increase in risk at a threshold of two SIRS criteria. CONCLUSIONS The need for two or more SIRS criteria to define severe sepsis excluded one in eight otherwise similar patients with infection, organ failure, and substantial mortality and failed to define a transition point in the risk of death.
引用
收藏
页码:1629 / 1638
页数:10
相关论文
共 27 条
  • [1] Systemic inflammatory response and progression to severe sepsis in critically ill infected patients
    Alberti, C
    Brun-Buisson, C
    Chevret, S
    Antonelli, M
    Goodman, SV
    Martin, C
    Moreno, R
    Ochagavia, AR
    Palazzo, M
    Werdan, K
    Le Gall, JR
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 171 (05) : 461 - 468
  • [2] Corticosteroid Treatment and Intensive Insulin Therapy for Septic Shock in Adults A Randomized Controlled Trial
    Annane, Djillali
    Cariou, Alain
    Maxime, Virginie
    Azoulay, Elie
    D'honneur, Gilles
    Timsit, Jean Francois
    Cohen, Yves
    Wolf, Michel
    Fartoukh, Muriel
    Adrie, Christophe
    Santre, Charles
    Bollaert, Pierre Edouard
    Mathonet, Armelle
    Amathieu, Roland
    Tabah, Alexis
    Clec'h, Christophe
    Mayaud, Julien
    Lejeune, Julie
    Chevret, Sylvie
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (04): : 341 - 348
  • [3] [Anonymous], JAMA
  • [4] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [5] EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units
    Brun-Buisson, C
    Meshaka, P
    Pinton, P
    Vallet, B
    Rodie-Talbere, P
    Zahar, JR
    [J]. INTENSIVE CARE MEDICINE, 2004, 30 (04) : 580 - 588
  • [6] Foreword
    Eckardt, Kai-Uwe
    Kasiske, Bertram L.
    [J]. KIDNEY INTERNATIONAL SUPPLEMENTS, 2012, 2 (01) : 7 - 7
  • [7] Benchmarking the Incidence and Mortality of Severe Sepsis in the United States
    Gaieski, David F.
    Edwards, J. Matthew
    Kallan, Michael J.
    Carr, Brendan G.
    [J]. CRITICAL CARE MEDICINE, 2013, 41 (05) : 1167 - 1174
  • [8] Lower versus Higher Hemoglobin Threshold for Transfusion in Septic Shock
    Holst, Lars B.
    Haase, Nicolai
    Wetterslev, Jorn
    Wernerman, Jan
    Guttormsen, Anne B.
    Karlsson, Sari
    Johansson, Par I.
    Aneman, Anders
    Vang, Marianne L.
    Winding, Robert
    Nebrich, Lars
    Nibro, Helle L.
    Rasmussen, Bodil S.
    Lauridsen, Johnny R. M.
    Nielsen, Jane S.
    Oldner, Anders
    Pettila, Ville
    Cronhjort, Maria B.
    Andersen, Lasse H.
    Pedersen, Ulf G.
    Reiter, Nanna
    Wiis, Jorgen
    White, Jonathan O.
    Russell, Lene
    Thornberg, Klaus J.
    Hjortrup, Peter B.
    Muller, Rasmus G.
    Moller, Morten H.
    Steensen, Morten
    Tjader, Inga
    Kilsand, Kristina
    Odeberg-Wernerman, Suzanne
    Sjobo, Brit
    Bundgaard, Helle
    Thyo, Maria A.
    Lodahl, David
    Maerkedahl, Rikke
    Albeck, Carsten
    Illum, Dorte
    Kruse, Mary
    Winkel, Per
    Perner, Anders
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (15) : 1381 - 1391
  • [9] Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study
    Karlsson, Sari
    Varpula, Marjut
    Ruokonen, Esko
    Pettila, Ville
    Parviainen, Ilkka
    Ala-Kokko, Tero I.
    Kolho, Elina
    Rintala, Esa M.
    [J]. INTENSIVE CARE MEDICINE, 2007, 33 (03) : 435 - 443
  • [10] Mortality Related to Severe Sepsis and Septic Shock Among Critically III Patients in Australia and New Zealand, 2000-2012
    Kaukonen, Kirsi-Maija
    Bailey, Michael
    Suzuki, Satoshi
    Pilcher, David
    Bellomo, Rinaldo
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (13): : 1308 - 1316